323
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Comprehensive analysis of differentially expressed long noncoding RNAs, miRNAs and mRNAs in breast cancer brain metastasis

, , , , & ORCID Icon
Pages 1113-1128 | Received 29 Apr 2021, Accepted 09 Jun 2021, Published online: 21 Jun 2021

References

  • Chang G , ShiL , YeYet al. YTHDF3 induces the translation of m(6)A-enriched gene transcripts to promote breast cancer brain metastasis. Cancer Cell38(6), 857–871.e857 (2020).
  • Bailleux C , EberstL , BachelotT. Treatment strategies for breast cancer brain metastases. Br. J. Cancer124(1), 142–155 (2021).
  • Riebensahm C , JoosseSA , MohmeMet al. Clonality of circulating tumor cells in breast cancer brain metastasis patients. Breast Cancer Res.21(1), 101–101 (2019).
  • Fu B , ZhangA , LiMet al. Circular RNA profile of breast cancer brain metastasis: identification of potential biomarkers and therapeutic targets. Epigenomics10(12), 1619–1630 (2018).
  • Tang D , ZhaoX , ZhangL , WangZ , WangC. Identification of hub genes to regulate breast cancer metastasis to brain by bioinformatics analyses. J. Cell. Biochem.120(6), 9522–9531 (2019).
  • Maiti A , HaitNC. Autophagy-mediated tumor cell survival and progression of breast cancer metastasis to the brain. J. Cancer12(4), 954–964 (2021).
  • Zhang L , FanM , NapolitanoF , GaoX , XuY , LiL. Transcriptomic analysis identifies organ-specific metastasis genes and pathways across different primary sites. J. Transl. Med.19(1), 31 (2021).
  • Liu Q , ZhangH , JiangX , QianC , LiuZ , LuoD. Factors involved in cancer metastasis: a better understanding to “seed and soil” hypothesis. Mol. Cancer16(1), 176 (2017).
  • Lu X , GaoC , LiuCet al. Identification of the key pathways and genes involved in HER2-positive breast cancer with brain metastasis. Pathol. Res. Pract.215(8), 152475 (2019).
  • Gao L , ZhaoY , MaX , ZhangL. Integrated analysis of lncRNA-miRNA-mRNA ceRNA network and the potential prognosis indicators in sarcomas. BMC Med. Genomics14(1), 67 (2021).
  • Ma Y , MaL , CaoY , ZhaiJ. Construction of a ceRNA-based lncRNA-mRNA network to identify functional lncRNAs in polycystic ovarian syndrome. Aging13(6), 8481–8496 (2021).
  • Chu KJ , MaYS , JiangXHet al. Whole-transcriptome sequencing identifies key differentially expressed mRNAs, miRNAs, lncRNAs, and circRNAs associated with CHOL. Mol. Ther. Nucleic Aids21, 592–603 (2020).
  • Chen Y , MaoZD , ShiYJet al. Comprehensive analysis of miRNA-mRNA-lncRNA networks in severe asthma. Epigenomics doi:10.2217/epi-2018-0132 (2018) ( Epub ahead of print).
  • Gao Y , ZangQ , SongHet al. Comprehensive analysis of differentially expressed profiles of non-coding RNAs in peripheral blood and ceRNA regulatory networks in non-syndromic orofacial clefts. Mol. Med. Rep.20(1), 513–528 (2019).
  • Dun MD , ChalkleyRJ , FaulknerSet al. Proteotranscriptomic profiling of 231-br breast cancer cells: identification of potential biomarkers and therapeutic targets for brain metastasis. Mol. Cell. Proteomics14(9), 2316–2330 (2015).
  • Li L , PengM , XueWet al. Integrated analysis of dysregulated long non-coding RNAs/microRNAs/mRNAs in metastasis of lung adenocarcinoma. J. Transl. Med.16(1), 372–372 (2018).
  • Botti G , ScognamiglioG , AquinoG , LiguoriG , CantileM. LncRNA HOTAIR in tumor microenvironment: what role?Int. J. Mol. Sci.20(9), 2279 (2019).
  • Lin C , YangL. Long noncoding RNA in cancer: wiring signaling circuitry. Trends Cell Biol.28(4), 287–301 (2018).
  • Yang F , DengX , MaWet al. The lncRNA FIRRE anchors the inactive X chromosome to the nucleolus by binding CTCF and maintains H3K27me3 methylation. Genome Biol.16(1), 52 (2015).
  • Shi X , CuiZ , LiuXet al. LncRNA FIRRE is activated by MYC and promotes the development of diffuse large B-cell lymphoma via Wnt/β-catenin signaling pathway. Biochem. Biophys. Res. Commun.510(4), 594–600 (2019).
  • Zhu W , ZhouBL , RongLJet al. Roles of PTBP1 in alternative splicing, glycolysis, and oncogensis. J. Zhejiang Univ. Sci. B21(2), 122–136 (2020).
  • Li X , HanF , LiuW , ShiX. PTBP1 promotes tumorigenesis by regulating apoptosis and cell cycle in colon cancer. Bull. Cancer105(12), 1193–1201 (2018).
  • Shen L , LeiS , ZhangBet al. Skipping of exon 10 in Axl pre-mRNA regulated by PTBP1 mediates invasion and metastasis process of liver cancer cells. Theranostics10(13), 5719–5735 (2020).
  • Wang X , LiY , FanY , YuX , MaoX , JinF. PTBP1 promotes the growth of breast cancer cells through the PTEN/Akt pathway and autophagy. J. Cell. Physiol.233(11), 8930–8939 (2018).
  • Lee M , SongY , ChoiIet al. Expression of HYOU1 via reciprocal crosstalk between NSCLC cells and HUVECs control cancer progression and chemoresistance in tumor spheroids. Mol. Cells44(1), 50–62 (2021).
  • Rao S , OyangL , LiangJet al. Biological function of HYOU1 in tumors and other diseases. OncoTargets Ther.14, 1727–1735 (2021).
  • Li X , ZhangNX , YeHYet al. HYOU1 promotes cell growth and metastasis via activating PI3K/AKT signaling in epithelial ovarian cancer and predicts poor prognosis. Eur. Rev. Med. Pharmacol. Sci.23(10), 4126–4135 (2019).
  • Hao A , WangY , ZhangXet al. Long non-coding antisense RNA HYOU1-AS is essential to human breast cancer development through competitive binding hnRNPA1 to promote HYOU1 expression. Biochim. Biophys. Acta Mol. Cell Res.1868(4), 118951 (2021).
  • Ye J , XuM , TianX , CaiS , ZengS. Research advances in the detection of miRNA. J. Pharm. Anal.9(4), 217–226 (2019).
  • Su K , WangN , ShaoQ , LiuH , ZhaoB , MaS. The role of a ceRNA regulatory network based on lncRNA MALAT1 site in cancer progression. Biomed. Pharmacother.137, 111389 (2021).
  • Zhao M , FengJ , TangL. Competing endogenous RNAs in lung cancer. Cancer Biol. Med.18(1), 1–20 (2021).
  • Liang Y , SongX , LiYet al. LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis. Mol. Cancer19(1), 85 (2020).
  • Luo J , XieK , GaoXet al. Long noncoding RNA nuclear paraspeckle assembly transcript 1 promotes progression and angiogenesis of esophageal squamous cell carcinoma through miR-590-3p/MDM2 axis. Front. Oncol.10, 618930 (2020).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.